Literature DB >> 3195158

A study of HLA antigens in Behçet's syndrome.

S Lee, Y J Koh, D H Kim, D Bang, I W Nam, K H Lee, K Park.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3195158     DOI: 10.3349/ymj.1988.29.3.259

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


× No keyword cloud information.
  7 in total

1.  Primary association of HLA-B51 with Behçet's disease in Ireland.

Authors:  D J Kilmartin; A Finch; R W Acheson
Journal:  Br J Ophthalmol       Date:  1997-08       Impact factor: 4.638

2.  Polymerase chain reaction reveals herpes simplex virus DNA in saliva of patients with Behçet's disease.

Authors:  S Lee; D Bang; Y H Cho; E S Lee; S Sohn
Journal:  Arch Dermatol Res       Date:  1996-04       Impact factor: 3.017

3.  Association of the MIC-A gene and HLA-B51 with Behçet's disease in Arabs and non-Ashkenazi Jews in Israel.

Authors:  R Cohen; S Metzger; M Nahir; T Chajek-Shaul
Journal:  Ann Rheum Dis       Date:  2002-02       Impact factor: 19.103

Review 4.  HLA-B51/B5 and the risk of Behçet's disease: a systematic review and meta-analysis of case-control genetic association studies.

Authors:  Mathilde de Menthon; Michael P Lavalley; Carla Maldini; Loïc Guillevin; Alfred Mahr
Journal:  Arthritis Rheum       Date:  2009-10-15

5.  Clinical analysis of Behçet disease: arthritic manifestations in Behçet disease may present as seronegative rheumatoid arthritis or palindromic rheumatism.

Authors:  J H Park
Journal:  Korean J Intern Med       Date:  1999-01       Impact factor: 2.884

6.  A Rare Case of Vasculitis Patched Necrosis of Cecum due to Behçet's Disease.

Authors:  Ehsan Shahverdi; Mehdi Morshedi; Faraneh Oraei-Abbasian; Maryam Allahverdi Khani; Roya Khodayarnejad
Journal:  Case Rep Surg       Date:  2017-05-18

Review 7.  Pathogenesis of Non-Infectious Uveitis Elucidated by Recent Genetic Findings.

Authors:  Masaki Takeuchi; Nobuhisa Mizuki; Shigeaki Ohno
Journal:  Front Immunol       Date:  2021-04-12       Impact factor: 7.561

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.